Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium

被引：187
|
作者：
Csaky, Karl G. [1 ]
Richman, Elaine A. [2 ]
Ferris, Frederick L., III [3 ]
机构：
[1] Duke Univ, Med Ctr, Ophthalm Unit, DCRI, Durham, NC 27710 USA
[2] Richman Associates LLC, Baltimore, MD USA
[3] NEI, NIH, Div Epidemiol & Clin Res, Bethesda, MD 20892 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2008年 / 49卷 / 02期
关键词：
D O I：
10.1167/iovs.07-1132
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：479 / 489
页数：11
相关论文
共 50 条
  • [1] Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop
    Nair, Prashant
    Aiello, Lloyd Paul
    Gardner, Thomas W.
    Jampol, Lee M.
    Ferris, Frederick L., III
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (13) : 5127 - 5142
  • [2] The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium
    Weinreb, Robert N.
    Kaufman, Paul L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (04) : 1497 - 1505
  • [3] Use of Patient-Reported Outcomes in Medical Product Development: A Report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium
    Varma, Rohit
    Richman, Elaine A.
    Ferris, Frederick L., III
    Bressler, Neil M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (12) : 6095 - 6103
  • [4] Glaucoma Research Community and FDA Look to the Future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: Measures of Structural Change and Visual Function
    Weinreb, Robert N.
    Kaufman, Paul L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (11) : 7842 - 7851
  • [5] Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases
    Csaky, Karl
    Ferris, Frederick, III
    Chew, Emily Y.
    Nair, Prashant
    Cheetham, Janet K.
    Duncan, Jacque L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (09) : 3456 - 3463
  • [6] Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR public workshop
    Bast, Robert C.
    Thigpen, J. Tate
    Arbuck, Susan G.
    Basen-Engquist, Karen
    Burke, Laurie B.
    Freedman, Ralph
    Horning, Sandra J.
    Ozols, Robert
    Rustin, Gordon J.
    Spriggs, David
    Wenzel, Lari B.
    Pazdur, Richard
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 173 - 176
  • [7] Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies
    Levin, Leonard A.
    Sengupta, Mohor
    Balcer, Laura J.
    Kupersmith, Mark J.
    Miller, Neil R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (04)
  • [8] IPF clinical trial design and endpoints
    Nathan, Steven D.
    Meyer, Keith C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 463 - 471
  • [9] Issues in clinical trial design from the FDA perspective
    Katz, R
    EPILEPSIA, 2003, 44 : 9 - 15
  • [10] Trial design and endpoints in clinical transplant research
    Knight, Simon R.
    Morris, Peter J.
    Schneeberger, Stefan
    Pengel, Liset H. M.
    TRANSPLANT INTERNATIONAL, 2016, 29 (08) : 870 - 879
12345